Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
285130.KS Stock Summary
Top 10 Correlated ETFs
285130.KS
In the News
285130.KS Financial details
Company Rating
Buy
Market Cap
1122.94B
Income
122.06B
Revenue
1794.44B
Book val./share
-
Cash/share
-
Dividend
1500
Dividend %
2.29%
Employees
1.22K
Optionable
No
Shortable
Yes
Earnings
07 Feb 2024
P/E
9.78
Forward P/E
-
PEG
-1.26
P/S
0.66
P/B
0.56
P/C
-
P/FCF
-2.07
Quick Ratio
-
Current Ratio
2.98
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
4.74K
EPS next Y
-
EPS next Q
-
EPS this Y
-52.93%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
100.65%
Revenue last 5Y
5.99%
Revenue Q/Q
56.58%
EPS Q/Q
-469.47%
-
-
-
-
SMA20
7.59%
SMA50
4.46%
SMA100
-1.1%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
6%
ROC
0.03%
Gross Margin
29%
Oper. Margin
6%
Profit Margin
7%
Payout
6%
Shs Outstand
18.01M
Shs Float
10.31M
-
-
-
-
Target Price
-
52W Range
55600.0-86700.0
52W High
-24.34%
52W Low
+17.99%
RSI
66
Rel Volume
-
Avg Volume
44.27K
Volume
Perf Week
2.02%
Perf Month
15.9%
Perf Quarter
-10.38%
Perf Half Y
-12.77%
-
-
-
-
Beta
1.0851
-
-
Volatility
368.12%, 2640.04%
Prev Close
0.61%
Price
65600
Change
0%
285130.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 69.13K | 72.01K | 69.04K | 118.72K | 94.78K | |
Net income per share | 304.67 | 253.35 | 510.12 | 21.06K | 9.91K | |
Operating cash flow per share | 3.4K | 6.16K | 14.04K | 28.94K | -9.66K | |
Free cash flow per share | -865.76 | -388.73 | 8.52K | 20.58K | -25.35K | |
Cash per share | 9.13K | 13.76K | 24.25K | 116.45K | 89.11K | |
Book value per share | 34.97K | 36.11K | 54.16K | 116.67K | 111.23K | |
Tangible book value per share | 34.73K | 34.37K | 52.4K | 143.3K | 137.67K | |
Share holders equity per share | 34.97K | 36.11K | 54.16K | 116.67K | 111.23K | |
Interest debt per share | 47.87K | 58.71K | 41.66K | 28.25K | 38.47K | |
Market cap | 919.39B | 845.68B | 4603.67B | 2622.66B | 1412.78B | |
Enterprise value | 1789.55B | 1792.09B | 5225.53B | 2853.78B | 1739.68B | |
P/E ratio | 152.52 | 168.41 | 512.95 | 7.08 | 7.39 | |
Price to sales ratio | 0.67 | 0.59 | 3.79 | 1.26 | 0.77 | |
POCF ratio | 13.65 | 6.92 | 18.64 | 5.15 | -7.57 | |
PFCF ratio | -53.67 | -109.76 | 30.72 | 7.24 | -2.89 | |
P/B Ratio | 1.33 | 1.18 | 4.83 | 1.28 | 0.66 | |
PTB ratio | 1.33 | 1.18 | 4.83 | 1.28 | 0.66 | |
EV to sales | 1.31 | 1.26 | 4.3 | 1.37 | 0.95 | |
Enterprise value over EBITDA | 13.08 | 10.6 | 24.71 | 4.47 | 5.11 | |
EV to operating cash flow | 26.56 | 14.67 | 21.16 | 5.6 | -9.33 | |
EV to free cash flow | -104.47 | -232.59 | 34.87 | 7.88 | -3.56 | |
Earnings yield | 0.01 | 0.01 | 0 | 0.14 | 0.14 | |
Free cash flow yield | -0.02 | -0.01 | 0.03 | 0.14 | -0.35 | |
Debt to equity | 1.32 | 1.58 | 0.74 | 0.24 | 0.34 | |
Debt to assets | 0.47 | 0.53 | 0.33 | 0.12 | 0.18 | |
Net debt to EBITDA | 6.36 | 5.6 | 2.94 | 0.36 | 0.96 | |
Current ratio | 1.21 | 1.1 | 1.43 | 2.56 | 2.38 | |
Interest coverage | 1.44 | 2.41 | 4.36 | 52.38 | 14.91 | |
Income quality | -4.1 | 24.32 | 0.97 | 1.9 | -0.81 | |
Dividend Yield | 0 | 0.01 | 0 | 0.01 | 0.05 | |
Payout ratio | 0 | 1.05 | 0.67 | 0.07 | 0.35 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0.04 | 0.05 | 0.05 | 0.04 | 0.05 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
Capex to operating cash flow | -1.25 | -1.06 | -0.39 | -0.29 | 1.62 | |
Capex to revenue | -0.06 | -0.09 | -0.08 | -0.07 | -0.17 | |
Capex to depreciation | -0.95 | -1.26 | -0.99 | -1.58 | -3.31 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 15.48K | 14.35K | 24.93K | 235.1K | 157.48K | |
ROIC | -0.09 | 0.01 | 0.03 | 0.15 | 0.08 | |
Return on tangible assets | 0 | 0 | 0 | 0.09 | 0.05 | |
Graham Net | -36.82K | -42.21K | -24.15K | 64.03K | 49.94K | |
Working capital | 122.86B | 73.16B | 277.61B | 1697.41B | 1459.87B | |
Tangible asset value | 687.22B | 681.28B | 921.98B | 2522.32B | 2657.13B | |
Net current asset value | -508.08B | -620.98B | -237.75B | 1395.16B | 1281.92B | |
Invested capital | 1.32 | 1.58 | 0.74 | 0.24 | 0.34 | |
Average receivables | 206.38B | 193.21B | 214.25B | 316.36B | 353.94B | |
Average payables | 152.46B | 148.29B | 114.79B | 125.94B | 131.67B | |
Average inventory | 309.61B | 329.78B | 291.77B | 301.11B | 416.03B | |
Days sales outstanding | 53.9 | 47.17 | 73.33 | 67.89 | 63.7 | |
Days payables outstanding | 50.23 | 48.35 | 35.36 | 50.8 | 28.62 | |
Days of inventory on hand | 109.62 | 109.58 | 106.8 | 105.52 | 145.13 | |
Receivables turnover | 6.77 | 7.74 | 4.98 | 5.38 | 5.73 | |
Payables turnover | 7.27 | 7.55 | 10.32 | 7.19 | 12.75 | |
Inventory turnover | 3.33 | 3.33 | 3.42 | 3.46 | 2.51 | |
ROE | 0.01 | 0.01 | 0.01 | 0.18 | 0.09 | |
Capex per share | -4.27K | -6.55K | -5.52K | -8.36K | -15.69K |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 22.55K | 24.73K | 18.96K | 23.1K | 0 | |
Net income per share | 1.82K | 3.85K | 595.58 | -661 | 0 | |
Operating cash flow per share | 1.69K | 1.34K | -4.45K | -5.11K | 0 | |
Free cash flow per share | -2.38K | -4.14K | -12.79K | -12.36K | 0 | |
Cash per share | 91.04K | 89.11K | 92.32K | 94.66K | 0 | |
Book value per share | 107.54K | 111.23K | 111.56K | 132.4K | 0 | |
Tangible book value per share | 133.61K | 137.67K | 137.83K | 163.51K | 0 | |
Share holders equity per share | 107.54K | 111.23K | 111.56K | 132.4K | 0 | |
Interest debt per share | 35.52K | 37.95K | 52.6K | 61.88K | 0 | |
Market cap | 1745.65B | 1412.78B | 1431.88B | 1128.61B | 0 | |
Enterprise value | 2161.06B | 1739.68B | 1797.73B | 1619.9B | 0 | |
P/E ratio | 12.53 | 4.75 | 31.27 | -26.55 | 0 | |
Price to sales ratio | 4.04 | 2.96 | 3.93 | 3.04 | 0 | |
POCF ratio | 53.79 | 54.5 | -16.75 | -13.74 | 0 | |
PFCF ratio | -38.28 | -17.7 | -5.82 | -5.68 | 0 | |
P/B Ratio | 0.85 | 0.66 | 0.67 | 0.53 | 0 | |
PTB ratio | 0.85 | 0.66 | 0.67 | 0.53 | 0 | |
EV to sales | 5 | 3.65 | 4.93 | 4.36 | 0 | |
Enterprise value over EBITDA | 22.13 | 37.84 | 18.36 | 79.8 | 0 | |
EV to operating cash flow | 66.59 | 67.11 | -21.03 | -19.72 | 0 | |
EV to free cash flow | -47.39 | -21.79 | -7.31 | -8.15 | 0 | |
Earnings yield | 0.02 | 0.05 | 0.01 | -0.01 | 0 | |
Free cash flow yield | -0.03 | -0.06 | -0.17 | -0.18 | 0 | |
Debt to equity | 0.33 | 0.34 | 0.47 | 0.46 | 0 | |
Debt to assets | 0.18 | 0.18 | 0.24 | 0.24 | 0 | |
Net debt to EBITDA | 4.25 | 7.11 | 3.74 | 24.2 | 0 | |
Current ratio | 2.54 | 2.38 | 2.32 | 3.04 | 2.98 | |
Interest coverage | 19.62 | 4.09 | -1.45 | -1.55 | 0 | |
Income quality | 0.77 | 0.31 | -7.47 | 5.31 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.22 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.02 | 0.01 | 0.24 | 0.02 | 0.18 | |
Research and developement to revenue | 0.06 | 0.06 | 0.07 | 0.1 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Capex to operating cash flow | -2.41 | -4.08 | 1.88 | 1.42 | 0 | |
Capex to revenue | -0.18 | -0.22 | -0.44 | -0.31 | 0 | |
Capex to depreciation | -3.4 | -4.45 | -6.46 | -4.08 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 66.27K | 98.2K | 38.66K | 44.37K | 0 | |
ROIC | 0.02 | 0.01 | 0 | 0 | 0.03 | |
Return on tangible assets | 0.01 | 0.02 | 0 | 0 | 0.01 | |
Graham Net | 52.12K | 49.94K | 38.72K | 39.28K | 0 | |
Working capital | 1546.98B | 1459.87B | 1476.52B | 1602.88B | 1511.36B | |
Tangible asset value | 2563.11B | 2657.13B | 2648.99B | 2628.72B | 2700.63B | |
Net current asset value | 1327.31B | 1281.92B | 1087.12B | 989.74B | 860.83B | |
Invested capital | 0.33 | 0.34 | 0.47 | 0.46 | 0 | |
Average receivables | 310.8B | 307.57B | 306.41B | 309.16B | 162.35B | |
Average payables | 131.12B | 118.34B | 102.98B | 95.89B | 40.51B | |
Average inventory | 471.26B | 498.35B | 499.92B | 524.1B | 265.55B | |
Days sales outstanding | 61.57 | 60.2 | 72.5 | 78.7 | 0 | |
Days payables outstanding | 45.61 | 25.85 | 37.4 | 25.89 | 0 | |
Days of inventory on hand | 165.67 | 131.09 | 174.6 | 169.74 | 0 | |
Receivables turnover | 1.46 | 1.49 | 1.24 | 1.14 | 0 | |
Payables turnover | 1.97 | 3.48 | 2.41 | 3.48 | 0 | |
Inventory turnover | 0.54 | 0.69 | 0.52 | 0.53 | 0 | |
ROE | 0.02 | 0.03 | 0.01 | 0 | 0.02 | |
Capex per share | -4.07K | -5.48K | -8.34K | -7.25K | 0 |
285130.KS Frequently Asked Questions
What is SK Chemicals Co.,Ltd. stock symbol ?
SK Chemicals Co.,Ltd. is a KR stock and trading under the symbol 285130.KS
What is SK Chemicals Co.,Ltd. stock quote today ?
SK Chemicals Co.,Ltd. stock price is $65600 today.
Is SK Chemicals Co.,Ltd. stock public?
Yes, SK Chemicals Co.,Ltd. is a publicly traded company.